Lexeo Therapeutics prices $135 million public offering and placement
PositiveFinancial Markets

Lexeo Therapeutics has successfully priced a public offering and placement, raising $135 million. This significant funding will bolster their research and development efforts, allowing them to advance their innovative therapies. The move is a strong indicator of investor confidence in the company's potential to make impactful contributions to the healthcare sector.
— Curated by the World Pulse Now AI Editorial System